特发性肺纤维化患者癌症发病风险:韩国全国性队列研究
该研究基于韩国全国数据库,纳入2009至2014年特发性肺纤维化(IPF)患者25 241例及匹配对照75 723例,比较癌症发病率。IPF组总体癌症发病率为29.0例/1000人年,显著高于非IPF组(HR 2.09,95%CI 1.96-2.16),其中肺癌风险最高(HR 5.89,95%CI 5.40-6.42),淋巴瘤、皮肤癌等亦升高。
要点
- IPF患者总体癌症风险约为非IPF人群的2倍(HR 2.09)。
- 肺癌风险升高最显著(HR 5.89),淋巴瘤、皮肤癌等亦增加。
- 调整吸烟等因素后癌症风险仍显著升高。
核心结论
- IPF组癌症发病风险高于非IPF组,医疗提供者治疗IPF患者时应意识到该风险。
研究设计与样本
- 基于韩国全国数据库的人群队列研究,纳入2009至2014年IPF患者25 241例,按3:1随机匹配对照75 723例,排除基线前任何恶性肿瘤者。
- 采用多变量Cox回归模型评估癌症发病风险,癌症发病率以每1000人年事件数表示。
主要发现
- IPF组总体癌症发病率为29.0例/1000人年,显著高于非IPF组(HR 2.09;95%CI 1.96-2.16)。
- 肺癌HR最高(5.89;95%CI 5.40-6.42),其后依次为淋巴瘤、皮肤癌、子宫颈癌、多发性骨髓瘤、甲状腺癌、白血病、胰腺癌、肝癌和前列腺癌。
- 调整吸烟及其他癌症相关协变量对总体及特定癌症的HR影响很小。
临床怎么用
- 治疗IPF患者时应警惕其癌症发病风险升高,尤其肺癌风险显著增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: IPF shares common risk factors and has pathogenic similarities with cancer. However, limited population-based data are available on cancer risk among patients with IPF. Herein, we investigated whether IPF is associated with an increased risk for cancer incidence from a nationwide database in South Korea. METHODS: In this population-based cohort study, patients with IPF were enrolled from 2009 to 2014, and matched controls were randomly selected at a control-to-case ratio of 3:1. In both groups, individuals diagnosed with any malignancy before the index date were excluded. The incidence rates of cancer were measured as the number of events per 1000 person-years. Multivariable Cox regression models were used to assess the cancer incidence risk. RESULTS: This study included 25 241 patients with IPF and 75 723 matched controls. The overall cancer incidence in patients with IPF was 29.0 cases per 1000 person-years, and it was significantly higher in the IPF group than in the non-IPF group (HR, 2.09; 95% CI, 1.96-2.16). Lung cancer showed the highest HR (5.89; 95% CI, 5.40-6.42), followed by lymphoma, skin, uterine cervical, multiple myeloma, thyroid, leukaemia, pancreatic, liver and prostate cancer. Moreover, adjustment for the effects of smoking and other cancer-associated covariates had little effect on the HR of overall and specific cancers. CONCLUSION: The cancer incidence risk was higher in the IPF group than in the non-IPF group. Therefore, healthcare providers should be aware of this risk when treating patients with IPF.
引用
- Lee HY, Lee J, Lee CH, et al. Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study. Respirology. 2020. PMID: 33145926. doi:10.1111/resp.13911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。